Stock market announcement archive

May 30, 2023
Lifecare, which is developing a long-lasting glucose sensor with the size of agrain of rice, is launching a new company called Lifecare Veterinary. Now man'sbest friend will also benefit from the same innovation. - Our main focus will still be the development of the sensor for people withdiabetes, increasing their quality of life. This is […]
Read more
May 24, 2023
Lifecare will attend the Redeye Diabetes Event 2023 today and presents thecompany's technology status and development at 11:05 AM CEST. The presentations are live broadcasted athttps://www.redeye.se/events/870294/redeye-theme-diabetes and the presentationslides is enclosed to this notification. ABOUT LIFECARELifecare AS is a clinical stage medical sensor company developing technology forsensing and monitoring of various body analytes. Lifecare's main […]
Read more
May 22, 2023
Lifecare CEO Joacim Holter will presents the company's technology status anddevelopment at Redeye Diabetes Event 2023 on May 24 at 11:05 AM CEST. The presentations are live broadcasted athttps://www.redeye.se/events/870294/redeye-theme-diabetesABOUT LIFECARELifecare AS is a clinical stage medical sensor company developing technology forsensing and monitoring of various body analytes. Lifecare's main focus is tobring the next generation […]
Read more
May 12, 2023
Bergen, Norway 12 May 2023 Lifecare's latest updates include information of the recently finalized clinicalstudy and the presentation of study results on the upcoming American DiabetesAssociation Congress in San Diego, the company's Q1 2023 report, ISO 9001certification of Lifecare Laboratory and the progress for our plannedmanufacturing site in Mainz, Germany. Read more in Lifecare's newsletter […]
Read more
May 11, 2023
Today we can announce that we have finalized the Sencell Clinical Development Study (LFC-SEN-001) and it reveals accurate sensor performance in human subjects. - This is a very important step in the right direction to develop the next generation Continuous Glucose Monitor (CGM) for people with diabetes, says CEO Joacim Holter. In this first clinical […]
Read more
May 11, 2023
Lifecare AS will present Q1 2023 financial and operational status in a webcastThursday 11 May.The webcast will be for all shareholders and interested parties at 13:00 - 14:00CET. Lifecare CEO Joacim Holter will participate in the webcast. There will be aQ&A session following the presentation. The webcast will be available here:https://teams.microsoft.com/l/meetup-join/19%3ameeting_MDY4ZWM0YmMtOGJmMS00OGRlLTg0NGItOTRjNzM1NTNhNGM1%40thread.v2/0?context=%7b%22Tid%22%3a%22c5fbb1c6-4eb0-45db-9f3c-6e20ebcd710e%22%2c%22Oid%22%3a%2271082610-7009-40ed-92e6-70ae6bc35450%22%7d
Read more
May 10, 2023
Financial calendar for Lifecare ASFINANCIAL YEAR 202323.08.2023 - Half-yearly Report11.05.2023 - Quarterly Report - Q108.11.2023 - Quarterly Report - Q3This information is published pursuant to the requirements set out in theContinuing obligations.
Read more
May 5, 2023
Financial calendar for Lifecare ASFINANCIAL YEAR 202323.08.2023 - Half-yearly Report11.05.2023 - Quarterly Report - Q108.11.2023 - Quarterly Report - Q301.06.2023 - Capital Markets DayThis information is published pursuant to the requirements set out in theContinuing obligations.
Read more
May 5, 2023
Financial calendar for Lifecare ASFINANCIAL YEAR 202323.08.2023 - Half-yearly Report11.05.2023 - Quarterly Report - Q108.11.2023 - Quarterly Report - Q3This information is published pursuant to the requirements set out in theContinuing obligations.
Read more
April 27, 2023
In solemn circumstances yesterday late afternoon, Lifecare signed a lease fornew production facilities and a laboratory in Mainz, Germany. The letter ofintent entered into last autumn has thus been formalized with InnovationsparkMainz GmbH & Co KG.- The lease of production premises ensures modern and effective facilitiesneeded for Lifecares planned scale up of production, with necessary […]
Read more